Smiths' medical profits static but sales up 12%
This article was originally published in Clinica
Smiths Industries' medical systems division had profits of £75 million ($122 million) in the year ended August 1, the same as the previous year, despite sales growth of 12% to £344 million.
You may also be interested in...
A medtech industry group is asking the Trump administration to clarify if small medical device companies that have equity investors qualify for small business loans and forgiveness under the coronavirus relief package.
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
Grail announced results from an initial validation study that showed its early-detection blood test could identify 12 of the deadliest cancers with a low rate of false-positive results.